Back
SoftBank Group Vs. Akero Therapeutics Industry Stock Comparison
Sell
38
SFTBY
SoftBank Group
Last Price:
25.81
Seasonality Move:
8.73%
Sell
40
AKRO
Akero Therapeutics
Last Price:
19.64
Seasonality Move:
6.97%
Sell
38
SoftBank Group (SFTBY)
is a Sell
Is SoftBank Group a Buy, Sell or Hold?
- The current SoftBank Group [SFTBY] share price is $25.81. The Score for SFTBY is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- SFTBY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $19.66. The Score for AKRO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- AKRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SFTBY Stock Price Chart
What is SoftBank Group's stock price today?
-
The SoftBank Group share price today is $25.81
The current trend is relatively stagnant and SFTBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $19.66
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.
SFTBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.84 | Sell |
Relative Strength Index (14 RSI): | 47.64 | Sell |
Chaikin Money Flow: | 283424 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.6 - 28.04) | Sell |
Bollinger Bands (100): | (22.03 - 28.89) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.19 | Sell |
Relative Strength Index (14 RSI): | 35.02 | Sell |
Chaikin Money Flow: | -513518 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.95 - 22.91) | Sell |
Bollinger Bands (100): | (20.21 - 26.05) | Sell |
SFTBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.95 | Buy |
20-day SMA: | 25.71 | Buy |
50-day SMA: | 27.96 | Sell |
200-day SMA: | 23.59 | Buy |
8-day EMA: | 25.11 | Buy |
20-day EMA: | 25.78 | Buy |
50-day EMA: | 26.48 | Sell |
200-day EMA: | 24.3 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 19.73 | Sell |
20-day SMA: | 20.95 | Sell |
50-day SMA: | 24.31 | Sell |
200-day SMA: | 28.19 | Sell |
8-day EMA: | 19.96 | Sell |
20-day EMA: | 20.99 | Sell |
50-day EMA: | 22.48 | Sell |
200-day EMA: | 27.07 | Sell |
SoftBank Group Earnings Growth & SFTBY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.19 per share, a decrease this year of $1.01 per share, and a decrease next year of $0.65 per share.
SoftBank Group Technical Analysis
Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |